Search Results 551-560 of 16865 for GLP-1 agonists

  1. Patient Perception of Dorsal Vaginal Graft Urethroplasty for Female Urethral Stricture Disease - Mayo Clinic

    Eligibility last updated 11/1/22. Questions regarding updates should be directed to the study team contact. Participating Mayo Clinic locations. Study ...

  2. LEGEND Study: A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High-Risk NMIBC Patients Who Are BCG Naïve or Received Incomplete BCG Treatment - Mayo Clinic

    LEGEND Study: A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High ...

  3. A Study to Establish a New Onset Hyperglycemia and Diabetes Cohort - Mayo Clinic

    Participation eligibility · Patient must have hyperglycemia and/or diabetes defined as one of the following in ≤ 90 days prior to the date of study consent. · * ...

  4. Medical Research & Education - Mayo Clinic News Network

    1 · 2 · 3 · 4 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery ...

  5. Pain Medicine - Overview - Mayo Clinic

    People with complex medical histories and pain syndromes might need more than one type of treatment and other approaches. Mayo Clinic's dedicated team of ...

  6. Digestive Diseases Clinical Trials - Medical Professionals

    One uncontrolled, unpublished study suggests that a footstool improved bowel ... 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) who are ...

  7. Neurology - Clinical trials - Mayo Clinic

    Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6- ...

  8. Clinical trials - Oncology (Medical)

    Avelumab In Combination Regimens That Include An Immune Agonist ... PTT-936, an Alpha Kinase 1 (ALPK1) Activator ... And I think that is one of the ...

  9. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

    About this study. To evaluate the effectiveness of NY-ESO-1-Specific (c259) T Cells, alone or in combination with other anti-cancer agents, in HLA-A*02:01, ...

  10. A Study of the Use of a New Drug in People with Non-Alcoholic Steatohepatitis (NASH) or Non-Alcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.